Log In
Print this Print this

Lonasen, blonanserin (AD-5423)

  Manage Alerts
Collapse Summary General Information
Company Sumitomo Dainippon Pharma Co. Ltd.
DescriptionCombined dopamine D2 and serotonin (5-HT2) receptor antagonist
Molecular Target Dopamine D2 receptor ; Serotonin (5-HT2) receptor
Mechanism of ActionDopamine receptor antagonist; Serotonin (5-HT) receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationSchizophrenia
Indication DetailsTreat schizophrenia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today